elacridar has been researched along with Brain Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakken, K; Elmquist, WF; Mittapalli, RK; Parrish, KE; Pokorny, J; Sarkaria, JN | 1 |
Beijnen, JH; Boogerd, W; Kemper, EM; van Tellingen, O; Verheij, M | 1 |
2 other study(ies) available for elacridar and Brain Neoplasms
Article | Year |
---|---|
Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Dogs; Drug Resistance, Neoplasm; Drug Synergism; Female; Glioblastoma; Heterografts; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Piperazines; Pyridines; Tetrahydroisoquinolines | 2015 |
Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Chemistry; Brain Neoplasms; Cyclosporins; Docetaxel; Drug Interactions; Female; Mice; Mice, Knockout; Taxoids; Tetrahydroisoquinolines | 2004 |